Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Borg

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
The British Journal of Surgery|May 11, 2019
Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancyZ Lakkis, D Vernerey, D Mege, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2016
Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinomaS Kim, S Paget-Bailly, M Messager, et al.
Journal of Global Oncology|October 16, 2018
International Radiotherapy Referrals From Rural Rwanda: Implementation Processes and Early Clinical OutcomesMaud Hanappe, Lowell T Nicholson, Shekinah N C Elmore, et al.
Oncoimmunology|May 4, 2018
PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinomaA Asgarova, K Asgarov, Y Godet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort studyF Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A long-chain heparan sulfate capture mechanism directs paracrine GDNF-GFRα1 signalling through RETMia I Zol-Hanlon, Beatrice Rix, Salomé Bodet-Lefèvre, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
ESMO Gastrointestinal Oncology|July 6, 2026
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trialA El Kaddissi, A Vienot, J-D Fumet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2020
Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929F Pagès, T André, J Taieb, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
The British Journal of Surgery|May 11, 2019
Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancyZ Lakkis, D Vernerey, D Mege, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2016
Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinomaS Kim, S Paget-Bailly, M Messager, et al.
Journal of Global Oncology|October 16, 2018
International Radiotherapy Referrals From Rural Rwanda: Implementation Processes and Early Clinical OutcomesMaud Hanappe, Lowell T Nicholson, Shekinah N C Elmore, et al.
Oncoimmunology|May 4, 2018
PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinomaA Asgarova, K Asgarov, Y Godet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort studyF Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A long-chain heparan sulfate capture mechanism directs paracrine GDNF-GFRα1 signalling through RETMia I Zol-Hanlon, Beatrice Rix, Salomé Bodet-Lefèvre, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
ESMO Gastrointestinal Oncology|July 6, 2026
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trialA El Kaddissi, A Vienot, J-D Fumet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2020
Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929F Pagès, T André, J Taieb, et al.
Pageof 10